IngentaConnect What Is Heartburn Worth?: A Cost-Utility Analysis of Management S...

Authors: Heudebert, Gustavo R.¹; Centor, Robert M.¹; Klapow, Joshua C.¹; Marks, Robert²; Johnson, Lawrence²; Wilcox, C. Mel²

Source: Journal of General Internal Medicine, Volume 15, Number 3, March 2000 , pp. 175-182(8)

Publisher: Blackwell Publishing

Abstract:

OBJECTIVE:

To determine the best treatment strategy for the management of patients presenting with symptoms consistent with uncomplicated heartburn. METHODS:

We performed a cost-utility analysis of 4 alternatives: empirical proton pump inhibitor, empirical histamine₂-receptor antagonist, and diagnostic strategies consisting of either esophagogastroduodenoscopy (EGD) or an upper gastrointestinal series before treatment. The time horizon of the model was 1 year. The base case analysis assumed a cohort of otherwise healthy 45-year-old individuals in a primary care practice. MAIN RESULTS:

Empirical treatment with a proton pump inhibitor was projected to provide the greatest quality-adjusted survival for the cohort. Empirical treatment with a histamine₂ receptor antagonist was projected to be the least costly of the alternatives. The marginal cost-effectiveness of using a proton pump inhibitor over a histamine₂-receptor antagonist was approximately $10,400 per quality-adjusted life year (QALY) gained in the base case analysis and was less than $50,000 per QALY as long as the utility for heartburn was less than 0.95. Both diagnostic strategies were dominated by proton pump inhibitor alternative. CONCLUSIONS:

Empirical treatment seems to be the optimal initial management strategy for patients with heartburn, but the choice between a proton pump inhibitor or histamine₂-receptor antagonist depends on the impact of heartburn on quality of life.

Keywords: cost-utility analysis; heartburn; proton pump inhibitor; histamine2-receptor antagonist; quality of life

Document Type: Research article

DOI: 10.1046/j.1525-1497.2000.02639.x

Affiliations: 1: Divisions of General Internal Medicine, University of Alabama at Birmingham, Birmingham, Ala. 2: Gastroenterology, University of Alabama at Birmingham, Birmingham, Ala.

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on Synergy.

You may be required to register and activate access on Synergy before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com

What Is Heartburn Worth?: A Cost-Utility Analysis of Management Strategies